復星醫藥(600196.SH)：硫代硫酸鈉注射液藥品註冊申請獲批准

智通財經網

03/20

智通財經APP訊，復星醫藥(600196.SH)公告，公司控股子公司重慶凱林製藥有限公司就硫代硫酸鈉注射液的藥品註冊申請獲國家藥品監督管理局批准。本次獲批適應症為用於氰化物中毒，也可用於砷、汞、鉛、鉍、碘等中毒。

更多港股重磅資訊，下載智通財經app

更多港股及海外理財資訊，請點擊www.zhitongcaijing.com（搜索「智通財經」）；欲加入智通港股投資群，請加智通客服微信(ztcjkf)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2620789489"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620789489\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620789489?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-03-20 16:57","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2620789489","market":"sh","top_or_hot":-1,"title":"復星醫藥(600196.SH)：硫代硫酸鈉注射液藥品註冊申請獲批准","media":"智通財經網","content":"<html><body><p>智通財經APP訊，<a href=\"https://laohu8.com/S/600196\">復星醫藥</a>(600196.SH)公告，公司控股子公司重慶凱林製藥有限公司就硫代硫酸鈉注射液的藥品註冊申請獲國家藥品監督管理局批准。本次獲批適應症為用於氰化物中毒，也可用於砷、汞、鉛、鉍、碘等中毒。</p><p>更多港股重磅資訊，下載智通財經app</p><p>更多港股及海外理財資訊，請點擊www.zhitongcaijing.com（搜索「智通財經」）；欲加入智通港股投資群，請加智通客服微信(ztcjkf)</p> </body></html>","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>復星醫藥(600196.SH)：硫代硫酸鈉注射液藥品註冊申請獲批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n復星醫藥(600196.SH)：硫代硫酸鈉注射液藥品註冊申請獲批准\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">智通財經網</strong><span class=\"h-time small\">2026-03-20 16:57</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><p>智通財經APP訊，<a href=\"https://laohu8.com/S/600196\">復星醫藥</a>(600196.SH)公告，公司控股子公司重慶凱林製藥有限公司就硫代硫酸鈉注射液的藥品註冊申請獲國家藥品監督管理局批准。本次獲批適應症為用於氰化物中毒，也可用於砷、汞、鉛、鉍、碘等中毒。</p><p>更多港股重磅資訊，下載智通財經app</p><p>更多港股及海外理財資訊，請點擊www.zhitongcaijing.com（搜索「智通財經」）；欲加入智通港股投資群，請加智通客服微信(ztcjkf)</p> </body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://www.zhitongcaijing.com/content/detail/1416581.html\">智通財經網</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0060","symbol_name":"抗癌","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1416581.html","article_id":"2620789489","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620789489","pubTimestamp":1773997060,"columns":[],"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"智通財經APP訊，復星醫藥(600196.SH)公告，公司控股子公司重慶凱林製藥有限公司就硫代硫酸鈉注射液的藥品註冊申請獲國家藥品監督管理局批准。本次獲批適應症為用於氰化物中毒，也可用於砷、汞、鉛、鉍、碘等中毒。更多港股重磅資訊，下載智通財經app更多港股及海外理財資訊，請點擊www.zhitongcaijing.com（搜索「智通財經」）；欲加入智通港股投資群，請加智通客服微信(ztcjkf)","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600196":"复星医药","BK0060":"抗癌","BK0187":"一线龙头","BK0028":"国家队","02196":"复星医药","BK1593":"医美概念股","BK0239":"医药制造","BK0196":"行业龙头","BK0183":"MSCI概念","BK0096":"民营医院","BK0188":"融资融券","BK1191":"制药","BK1515":"抗疫概念","BK0012":"证金概念","BK0175":"白马股"},"translate_title":"Fosun Pharma (600196.SH): Drug registration application for sodium thiosulfate injection approved","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":1.5,"02196":1.5},"content_text":"智通財經APP訊，復星醫藥(600196.SH)公告，公司控股子公司重慶凱林製藥有限公司就硫代硫酸鈉注射液的藥品註冊申請獲國家藥品監督管理局批准。本次獲批適應症為用於氰化物中毒，也可用於砷、汞、鉛、鉍、碘等中毒。更多港股重磅資訊，下載智通財經app更多港股及海外理財資訊，請點擊www.zhitongcaijing.com（搜索「智通財經」）；欲加入智通港股投資群，請加智通客服微信(ztcjkf)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}